VDR and colorectal carcinoma: Thus, further investigation into the molecular mechanisms by which coclaurine and reticuline inhibit CRC cell motility focusing on VDR downstream effectors, particularly the Wnt/β-catenin pathway, would be of interest for the discovery of potential therapeutic targets.